$BCDA
BioCardia, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$0.914
▲After hours+0.05%+$0.000After hours
BioCardia, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is BCDA down today? It is at $0.914 (-0.87%), and our scanner flagged it 4 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment BCDA spikes, and full due diligence on BCDA — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $BCDA 4 times in the last 30 days. Create a free account to track $BCDA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on BCDA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BCDA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystClinical / FDA update, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Oct 20, 2026 · 15 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Altman Peter Officer | Bought (open market) | +300 | added <0.1% | 385K | $285 at $0.950 | Oct 16, 26 |
Altman Peter Officer | Bought (open market) | +200 | added <0.1% | 385K | $190 at $0.950 | Oct 15, 26 |
Altman Peter Officer | Bought (open market) | +1K | added 0.3% | 385K | $1K at $1.03 | Sep 29, 26 |
Altman Peter Officer | Bought (open market) | +2K 0.01% of company | added 0.5% | 384K | $2K at $1.05 | Sep 23, 26 |
Altman Peter Officer | Bought (open market) | +800 | added 0.2% | 382K | $872 at $1.09 | Sep 3, 26 |
Altman Peter Officer | Bought (open market) | +5K 0.04% of company | added 1.4% | 381K | $5K at $0.930 | Aug 17, 26 |
Altman Peter Officer | Bought (open market) | +2K 0.01% of company | added 0.5% | 376K | $2K at $0.920 | Aug 13, 26 |
Altman Peter Officer | Bought (open market) | +5K 0.03% of company | added 1.4% | 374K | $4K at $0.780 | Jul 29, 26 |
Altman Peter Officer | Bought (open market) | +500 | added 0.1% | 369K | $415 at $0.830 | Jul 17, 26 |
Altman Peter Officer | Bought (open market) | +2K | added 0.4% | 368K | $1K at $0.860 | Jul 15, 26 |
Altman Peter Officer | Bought (open market) | +3K 0.02% of company | added 0.8% | 367K | $2K at $0.880 | Jul 14, 26 |
Altman Peter Officer | Bought (open market) | +1K | added 0.3% | 369K | $940 at $0.940 | Jul 10, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on BCDA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BCDA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
BCDA last traded at $0.914, down 0.87% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
BioCardia, Inc. Common Stock (BCDA) is next expected to report earnings on Wednesday, November 11, 2026, about 7 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The BCDA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged BCDA 4 times in the last 30 days.
BCDA (BioCardia, Inc. Common Stock) trades on XNAS, with a market cap of about $14M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge BCDA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$BCDA discussion
Sign in to ask a question or join the discussion.